Vera Therapeutics (VERA) Stock Price & Analysis

VERA$30.25—
BiotechnologyGrowth Stock
Compare
Market cap$2.03BEnterprise value$2.21BRevenue (TTM)$0Market position—

Score

68
Bullish
Value
58
Quality
45
Growth
100

AI Analysis

Snapshot

Vera Therapeutics is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 68/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~167% upside.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

58
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

45
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Vera Therapeutics, Inc. (VERA) last printed $30.25. Equity value is $2.03B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2019202020212022202320242025
$0.00$0.00$0.00$0.00$0.00$0.00$0.00

About

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is currently undergoing Phase IIb clinical trials to treat immunoglobulin A nephropathy. The company is also advancing MAU868, a monoclonal antibody in Phase 2 clinical development, designed to combat BK viremia infections. Founded in 2016 and based in Brisbane, California, the organization operated as Trucode Gene Repair, Inc. until it rebranded to Vera Therapeutics, Inc. in April 2020.

Vera Therapeutics (VERA) Stock Price & Analysis

VERA price $30.25 —

Ticker
VERA
Price
$30.25
Change
—
Market cap
$2.03B
Forward P/E
12.46
Dividend yield
0.00%
Beta
0.95
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
58
Quality
45
Growth
100

Stocklytics score rationale: value 58, quality 45, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener